Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS ORCHID PHARMA IPCA LABS/
ORCHID PHARMA
 
P/E (TTM) x 51.8 42.1 123.2% View Chart
P/BV x 5.4 7.8 69.5% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 IPCA LABS   ORCHID PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-23
ORCHID PHARMA
Mar-23
IPCA LABS/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs1,062439 242.2%   
Low Rs768273 281.2%   
Sales per share (Unadj.) Rs243.0163.1 148.9%  
Earnings per share (Unadj.) Rs19.413.5 143.3%  
Cash flow per share (Unadj.) Rs29.727.0 110.2%  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs230.3168.7 136.5%  
Shares outstanding (eoy) m253.7040.82 621.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.82.2 172.7%   
Avg P/E ratio x47.226.3 179.5%  
P/CF ratio (eoy) x30.813.2 233.4%  
Price / Book Value ratio x4.02.1 188.4%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m232,12014,522 1,598.4%   
No. of employees `000NANA-   
Total wages/salary Rs m12,876654 1,970.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,6426,659 925.7%  
Other income Rs m1,518194 781.1%   
Total revenues Rs m63,1606,853 921.6%   
Gross profit Rs m9,0331,235 731.4%  
Depreciation Rs m2,616548 477.4%   
Interest Rs m482329 146.5%   
Profit before tax Rs m7,453552 1,349.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5340-   
Profit after tax Rs m4,919552 890.4%  
Gross profit margin %14.718.5 79.0%  
Effective tax rate %34.00-   
Net profit margin %8.08.3 96.2%  
BALANCE SHEET DATA
Current assets Rs m51,8935,010 1,035.8%   
Current liabilities Rs m18,0583,719 485.6%   
Net working cap to sales %54.919.4 283.1%  
Current ratio x2.91.3 213.3%  
Inventory Days Days5157 89.3%  
Debtors Days Days61,180 0.5%  
Net fixed assets Rs m34,3367,242 474.1%   
Share capital Rs m254408 62.2%   
"Free" reserves Rs m58,1676,478 897.9%   
Net worth Rs m58,4206,886 848.3%   
Long term debt Rs m6,5181,488 437.9%   
Total assets Rs m86,22912,252 703.8%  
Interest coverage x16.52.7 614.6%   
Debt to equity ratio x0.10.2 51.6%  
Sales to assets ratio x0.70.5 131.5%   
Return on assets %6.37.2 87.1%  
Return on equity %8.48.0 105.0%  
Return on capital %12.210.5 116.1%  
Exports to sales %42.981.9 52.4%   
Imports to sales %13.337.6 35.3%   
Exports (fob) Rs m26,4345,452 484.9%   
Imports (cif) Rs m8,1782,501 326.9%   
Fx inflow Rs m26,4345,452 484.9%   
Fx outflow Rs m8,1782,726 300.0%   
Net fx Rs m18,2572,726 669.8%   
CASH FLOW
From Operations Rs m8,058183 4,394.2%  
From Investments Rs m-7,250-312 2,322.7%  
From Financial Activity Rs m5,072312 1,627.5%  
Net Cashflow Rs m5,881183 3,215.0%  

Share Holding

Indian Promoters % 46.3 69.8 66.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.8 18.6 240.3%  
FIIs % 10.3 4.1 248.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 30.2 178.1%  
Shareholders   82,809 36,931 224.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IPCA Labs vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs Orchid Pharma Share Price Performance

Period IPCA Labs Orchid Pharma S&P BSE HEALTHCARE
1-Day 3.49% 0.29% 1.18%
1-Month 4.42% -13.47% -0.75%
1-Year 56.71% 175.44% 61.82%
3-Year CAGR 9.51% -23.47% 18.16%
5-Year CAGR 20.92% 184.97% 19.79%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.